Thursday, October 22, 2020
1 PM EDT
The adoption of 3D models for use in drug discovery continues to accelerate, leading to the need for sophisticated, reliable software tools that enable users to extract pertinent information from complex multidimensional models. In this webinar, we invite Dr. James Evans, the CEO of PhenoVista, a leading CRO for custom high-content services, to present use cases where PhenoVista uses Olympus’ NoviSight™ analysis software to quantify models such as tumor spheroids and organoids. In addition, Olympus’ Brendan Brinkman will discuss the capabilities of NoviSight software.